SAREPTA THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
SAREPTA THERAPEUTICS, INC. (SRPT) reported Gain (Loss) on Disposition of Assets of -$88.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2019-05-08
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2019-03-31 was -$88.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was -$3.84M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was -$57.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2018-06-30 was -$27.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2018 was -$3.94M.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2017 was -$805.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2016 was -$293.00K.
- SAREPTA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2015 was -$197.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 395 month | Gain (Loss) on Disposition of Assets 398 month | Gain (Loss) on Disposition of Assets 401 month | Gain (Loss) on Disposition of Assets 404 month |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$88.00K 10-Q · filed 2019-05-08 | -$3.93M derived: sum of 2 quarters · filed 2019-05-08 | -$3.99M derived: sum of 3 quarters · filed 2019-05-08 | -$4.02M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2018-12-31 | -$3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$3.90M derived: sum of 2 quarters · filed 2019-02-28 | -$3.93M derived: sum of 3 quarters · filed 2019-02-28 | -$3.94M 10-K · filed 2019-02-28 | ||||
| 2018-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$84.00K derived: sum of 2 quarters · filed 2018-10-31 | -$94.00K 10-Q · filed 2018-10-31 | -$107.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2018-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$37.00K 10-Q · filed 2018-08-08 | -$50.00K derived: sum of 3 quarters · filed 2019-05-08 | -$238.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2018-03-31 | -$10.00K 10-Q · filed 2019-05-08 | -$23.00K derived: sum of 2 quarters · filed 2019-05-08 | -$211.00K derived: sum of 3 quarters · filed 2019-05-08 | -$330.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$201.00K derived: sum of 2 quarters · filed 2019-02-28 | -$320.00K derived: sum of 3 quarters · filed 2019-02-28 | -$805.00K 10-K · filed 2019-02-28 | ||||
| 2017-09-30 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$307.00K derived: sum of 2 quarters · filed 2018-10-31 | -$792.00K 10-Q · filed 2018-10-31 | -$1.04M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$604.00K 10-Q · filed 2018-08-08 | -$852.00K derived: sum of 3 quarters · filed 2019-02-28 | -$873.00K derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$485.00K 10-Q · filed 2018-05-03 | -$733.00K derived: sum of 2 quarters · filed 2019-02-28 | -$754.00K derived: sum of 3 quarters · filed 2019-02-28 | -$763.00K derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$269.00K derived: sum of 2 quarters · filed 2019-02-28 | -$278.00K derived: sum of 3 quarters · filed 2019-02-28 | -$293.00K 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$30.00K derived: sum of 2 quarters · filed 2017-11-01 | -$45.00K 10-Q · filed 2017-11-01 | -$62.00K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$24.00K 10-Q · filed 2017-08-03 | -$41.00K derived: sum of 3 quarters · filed 2018-03-01 | -$89.00K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | -$15.00K 10-Q · filed 2017-05-04 | -$32.00K derived: sum of 2 quarters · filed 2018-03-01 | -$80.00K derived: sum of 3 quarters · filed 2018-03-01 | -$81.00K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$65.00K derived: sum of 2 quarters · filed 2018-03-01 | -$66.00K derived: sum of 3 quarters · filed 2018-03-01 | -$197.00K 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$49.00K derived: sum of 2 quarters · filed 2016-11-07 | -$180.00K 10-Q · filed 2016-11-07 | -$256.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$132.00K 10-Q · filed 2016-08-09 | -$208.00K derived: sum of 3 quarters · filed 2017-02-28 | -$208.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$131.00K 10-Q · filed 2016-05-05 | -$207.00K derived: sum of 2 quarters · filed 2017-02-28 | -$207.00K derived: sum of 3 quarters · filed 2017-02-28 | -$253.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$76.00K derived: sum of 2 quarters · filed 2017-02-28 | -$122.00K derived: sum of 3 quarters · filed 2017-02-28 | -$128.00K 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$46.00K derived: sum of 2 quarters · filed 2015-11-05 | -$52.00K 10-Q · filed 2015-11-05 | -$182.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$52.00K 10-Q · filed 2015-08-06 | -$182.00K derived: sum of 3 quarters · filed 2016-02-25 | -$308.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$6.00K 10-Q · filed 2015-05-07 | -$136.00K derived: sum of 2 quarters · filed 2016-02-25 | -$262.00K derived: sum of 3 quarters · filed 2016-02-25 | -$400.00K derived: sum of 4 quarters · filed 2016-02-25 | -$3.23M 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$256.00K derived: sum of 2 quarters · filed 2016-02-25 | -$394.00K derived: sum of 3 quarters · filed 2016-02-25 | -$590.00K 10-K · filed 2016-02-25 | -$3.23M 10-K · filed 2014-03-03 | |||
| 2013-09-30 | -$126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$264.00K derived: sum of 2 quarters · filed 2014-11-06 | -$460.00K 10-Q · filed 2014-11-06 | -$635.00K derived: sum of 4 quarters · filed 2015-02-26 | -$3.10M 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$334.00K 10-Q · filed 2014-08-07 | -$509.00K derived: sum of 3 quarters · filed 2015-02-26 | -$568.00K derived: sum of 4 quarters · filed 2015-02-26 | -$2.97M 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | -$196.00K 10-Q · filed 2014-05-08 | -$371.00K derived: sum of 2 quarters · filed 2015-02-26 | -$430.00K derived: sum of 3 quarters · filed 2015-02-26 | |||||
| 2012-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$234.00K derived: sum of 2 quarters · filed 2015-02-26 | -$357.00K 10-K · filed 2015-02-26 | |||||
| 2012-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$182.00K 10-Q · filed 2013-11-12 | ||||||
| 2012-06-30 | -$123.00K 10-Q · filed 2013-08-08 | |||||||
| 2011-12-31 | -$190.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |